Cost-effectiveness of strategies to increase screening coverage for cervical cancer in Spain: the CRIVERVA study

BMC Public Health

Table 1 Population included in the CRICERVA project

Population	IG1 (letter)	IG2 (letter + leaflet)	IG3 (letter + leaflet + phone call)
Target population
< 40	3251	2847	3799
40-49	2444	2146	2812
50-59	1784	1900	2406
≥ 60	1489	1276	2010
Total	8968	8169	11027
Poorly screened population^a
< 40	1113	948	1449
40-49	1224	974	1750
50-59	798	754	1260
≥ 60	1062	925	1629
Total	4197	3601	6088
Answer to the intervention^b
< 40	879	862	1079
40-49	861	683	1050
50-59	611	589	932
≥ 60	604	491	963
Total	2955	2625	4024
Women screened by the intervention^c
< 40	449	392	576
40-49	512	381	665
50-59	314	318	584
≥ 60	303	276	571
Total	1578	1367	2396

^aInvited to participate because last screening was more than three and a half years ago
^bThose women who are contacted through any of the interventions and are willing to attend the GP visit
^cNumber of women who finally attend th GP visit

ISSN: 1471-2458